Kura Oncology, Inc. (KURA) insider trading.
In Q3 2026, insiders at Kura Oncology, Inc. reported 15 non-derivative transactions on 12 Forms 3, 4 and 5: 2 open-market purchases worth $2.4M and 12 sales worth $1.7M.
- Transactions
- 15
- Purchases (P)
- 2
- Sales (S)
- 12
- Net shares, P minus S
- 46,119
- Insiders
- 7
- Last filed
- 2026-09-29
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Powl Brian T. | Officer · Chief Commercial Officer | 4 | 0 | 4 |
| Leoni Mollie | Officer · Chief Medical Officer | 2 | 0 | 2 |
| Ford Kathleen | Officer · Chief Operating Officer | 2 | 0 | 2 |
| Bair Teresa Brophy | Officer · Chief Legal Officer | 2 | 0 | 2 |
| Burrows Francis | Officer · Chief Scientific Officer | 2 | 0 | 1 |
| Wilson Troy Edward | Director, Officer · President and CEO | 2 | 2 | 0 |
| Doyle Thomas James | Officer · SVP, Finance & Accounting | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-29 | Powl Brian T. | S (D) | 15,430 | $10.75 | 136,819 | Form 4 |
| 2026-09-29 | Leoni Mollie | S (D) | 28,802 | $10.75 | 141,095 | Form 4 |
| 2026-09-29 | Ford Kathleen | S (D) | 3,668 | $10.75 | 142,986 | Form 4 |
| 2026-09-28 | Powl Brian T. | S (D) | 9,020 | $10.5 | 160,249 | Form 4 |
| 2026-09-28 | Powl Brian T. | S (D) | 8,000 | $10.56 | 152,249 | Form 4 |
| 2026-09-28 | Doyle Thomas James | S (D) | 4,607 | $10.5 | 142,428 | Form 4 |
| 2026-09-28 | Leoni Mollie | S (D) | 12,448 | $10.5 | 169,897 | Form 4 |
| 2026-09-28 | Ford Kathleen | S (D) | 6,906 | $10.5 | 146,654 | Form 4 |
| 2026-09-28 | Bair Teresa Brophy | S (D) | 8,442 | $10.5 | 187,002 | Form 4 |
| 2026-09-24 | Burrows Francis | S (D) | 20,726 | $10.83 | 42,327 | Form 4 |
| 2026-09-24 | Burrows Francis | M (A) | 30,000 | $6.15 | 63,053 | Form 4 |
| 2026-08-24 | Wilson Troy Edward | P (A) | 100,000 | $12.39 | 479,194 | Form 4 |
| 2026-08-21 | Powl Brian T. | S (D) | 4,345 | $11.89 | 169,269 | Form 4 |
| 2026-08-19 | Bair Teresa Brophy | S (D) | 31,487 | $12.63 | 195,444 | Form 4 |
| 2026-08-17 | Wilson Troy Edward | P (A) | 100,000 | $11.12 | 379,194 | Form 4 |
Transaction codes in this quarter
Get KURA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1422143&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · KURA company page · Kura Oncology, Inc. on SEC.gov
Questions
Are insiders buying or selling Kura Oncology, Inc. (KURA)?
In Q3 2026, insiders at Kura Oncology, Inc. reported 15 non-derivative transactions on 12 Forms 3, 4 and 5: 2 open-market purchases worth $2.4M and 12 sales worth $1.7M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Kura Oncology, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/kura.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.